Viewing Study NCT05744557


Ignite Creation Date: 2025-12-24 @ 6:49 PM
Ignite Modification Date: 2026-01-02 @ 1:43 AM
Study NCT ID: NCT05744557
Status: TERMINATED
Last Update Posted: 2025-05-20
First Post: 2023-02-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Vapocoolant Analgesia for Breast Lymphoscintigraphy
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Overview

Official Title: Vapocoolant Analgesia for Breast Lymphoscintigraphy
Status: TERMINATED
Status Verified Date: 2025-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: \<75% accrued participants
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: To learn if applying vapocoolant anesthetic spray ("Nüm") on the surface of the intended injection site will reduce the pain/anxiety associated with breast injections.
Detailed Description: Primary Objectives:

1. Establish feasibility of topical vapocoolant in the setting of breast lymphoscintigraphy.
2. Demonstrate safety of topical vapocoolant in the setting of breast lymphoscintigraphy.

Secondary Objectives:

1. To assess patient pain intensity associated with the performance of breast lymphoscintigraphy.
2. To evaluate the attitude from patients about supporting the continued offering of topical vapocoolant in the breast lymphoscintigraphy clinic.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
NCI-2023-01629 OTHER NCI-CTRP Clinical Trials Registry View